ArticleMolecular cancer therapeutics2022

Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer.

James D Hampton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.